JPML Declines MDL for Samsung Galaxy Smartphone Lawsuits

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has denied a request to consolidate all lawsuits over the Samsung Galaxy Note 7 recall before one judge for coordinated pretrial proceedings.

Following reports of nearly 100 Samsung Galaxy Note 7 smartphone lithium ion batteries overheating, including at lest two dozen reports of burn injuries and other reports involving property damage, the electronics manufacturer issued a massive recall last year impacting nearly 2.5 million devices.

A number of product liability lawsuits and class action claims have been filed, alleging that Samsung sold a defectively designed and manufactured product.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

A group of plaintiffs filed a motion to transfer all cases to a single judge as part of a federal MDL, or multidistrict litigation, which is designed to reduce duplicative discovery into common issues, avoid conflicting pretrial rulings and to serve the convenience of the parties, witnesses and the courts.

Following a hearing last month, the U.S. JPML issued an order denying transfer (PDF) on April 5, indicating that there are currently too few cases filed, and differences in the cases that do not warrant consolidation.

“At oral argument, all counsel stated that they were amenable to coordinating discovery to eliminate duplicative depositions and document productions,” the JPML noted. “In these circumstances, alternatives to centralization, such as informal cooperation among the relatively few involved attorneys and coordination among the involved courts, are eminently feasible and will be sufficient to minimize any potential for duplicative discovery or inconsistent pretrial rulings.”

In December, Samsung noted that about 93% of the smartphones sold to consumers had been returned. It then sent out a software update that was designed to disable the remaining devices, which will prevent them from being recharged and eliminated their ability to work as a mobile device.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.